Pharmafile Logo
Pharmafocus logo
Advanced Search

Parties debate future of NHS

April 22, 2010
Sales and Marketing NHS, general election

The UK general election debates turned to health policy on Thursday, with the Lib Democrats, Conservatives and Labour outlining their …

News
Digital Pharma Guide footer

Digital marketing – can we talk?

April 22, 2010
Medical Communications digital pharma, social media

The internet and online developments such as YouTube, Twitter, Wikipedia and Facebook have already revolutionised how we communicate, and with …

Feature
Collie Turner Headshot high-res

HealthTalker appoints Collie Turner

April 22, 2010
Sales and Marketing Company news, HealthTalker, appointment, new hires, pharm marketing, sales and marketing

Collie Turner has joined US word-of-mouth marketing agency HealthTalker’s leadership team as senior director of strategic partnerships. She will focus on driving new …

Appointment
Genzyme

Genzyme fined $175m for manufacturing problems

April 22, 2010
Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …

News

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010
Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …

News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010
Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …

Appointment

Novartis shines in first quarter

April 21, 2010
Sales and Marketing 2010 financials, Alcon, Novartis

Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …

News

Astellas eyes oncology growth

April 21, 2010
Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …

News

Volcanic ash fallout hits pharma

April 21, 2010
Manufacturing and Production Clinical Supply Operations, disaster, logistics, supply chain

The headline news in the wake of the Icelandic volcano eruption has been of stranded passengers struggling to get home …

News

Secondary endpoints failure take shine off Benlysta

April 21, 2010
Sales and Marketing GSK, HGS, Lupus

GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …

News
UCF 010310

Wyeth’s Ursula Franklin joins Red Kite

April 21, 2010
Business Services, Sales and Marketing Red Kite, appointment, coaching, development, leadership, sales and marketing, strategic planning, strategy, training

Red Kite has appointed Ursula Franklin to head up its new Transformation division. She joins from Wyeth Europa, now part …

Appointment

GSK’s Arzerra conditionally approved in Europe

April 20, 2010
Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010
Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …

News

Emerging markets and generics poised to drive pharma growth

April 20, 2010
Sales and Marketing IMS, em, emerging markets

The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …

News

Lilly faces substantial costs from US health reform

April 20, 2010
Sales and Marketing 2010 financials, Obama, lilly

Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …

News

ABPI appoints Roche’s Paul Catchpole

April 20, 2010
Sales and Marketing ABPI, UK, appointment, sales and marketing

UK industry association the ABPI has appointed Paul Catchpole as director of value and access. He will join the association …

Appointment

Third Apotex plant cited in FDA warning letter

April 19, 2010
Manufacturing and Production Apotex, generics, manufacturing compliance

Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …

News

Trial boost for Merck KGaA’s cladribine

April 19, 2010
Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

News

Novartis set to boost generic portfolio

April 19, 2010
Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

News

MedImmune: building a biologics future

April 19, 2010
Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …

Feature
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026